<DOC>
	<DOC>NCT01384903</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of KW-3357 compared to plasma-derived antithrombin using multi-center, open-label, parallel-group, comparative method in patients with Disseminated Intravascular Coagulation (DIC) associated with infection.</brief_summary>
	<brief_title>An Open-label Study of KW-3357</brief_title>
	<detailed_description />
	<mesh_term>Disseminated Intravascular Coagulation</mesh_term>
	<mesh_term>Antithrombins</mesh_term>
	<mesh_term>Antithrombin III</mesh_term>
	<criteria>Meet the ACCP/SCCMdefined sepsis criteria Japanese Association for Acute Medicinedefined DIC criteria score &gt;= 4 Antithrombin activity &lt;= 70% Written informed consent from patient or guardian Anamnesis or complication of serious drug allergy Serious liver disorder, such as fulminant hepatitis and decompensated cirrhosis Pregnant, nursing, or possibly pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>